Ribosomal protein L39 pseudogene 31 (RPL39P31)

Ribosomal protein L39 pseudogene 31 (RPL39P31) is classified as a *processed pseudogene* in the human genome. It shares sequence similarity with the functional ribosomal protein L39 gene, but RPL39P31 itself does not produce a functional protein and has no known biological role or disease association. Like other pseudogenes corresponding to ribosomal protein genes, RPL39P31 is a remnant of gene duplication events and is not considered a valid molecular or therapeutic target[5][1]. Rationale and clarification: - **is_target**: Ribosomal protein L39 pseudogene 31 is a pseudogene and, by definition, does not encode a functional protein; therefore, it is not a drug, biologic, or therapeutic target[5][1]. - **is_incorrect**: This target is not a functional molecule. While the naming is syntactically correct, it is not a valid or actionable target for drug discovery or biomarker research. Pseudogenes, especially processed pseudogenes related to ribosomal proteins, are not targeted by drugs or considered in target-based therapy pipelines[5][1]. - **aliases**: The only clear alias found is RPL39_17_1495, found in functional genomics and gene annotation resources[5]. - **molecular_classifications**: Pseudogene, other. - No relevant biological functions, disease roles, interacting drugs, mechanisms of action, biomarkers, or safety concerns are supported for this entry. - The canonical functional gene, *RPL39* (ribosomal protein L39), encodes a structural protein of the 60S ribosomal subunit and is distinct from pseudogenes like RPL39P31[1].

Other names

RPL39_17_1495